We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP.

Genes & development | Jul 1, 2010

The sterol regulatory element-binding protein (SREBP) transcription factor family is a critical regulator of lipid and sterol homeostasis in eukaryotes. In mammals, SREBPs are highly active in the fed state to promote the expression of lipogenic and cholesterogenic genes and facilitate fat storage. During fasting, SREBP-dependent lipid/cholesterol synthesis is rapidly diminished in the mouse liver; however, the mechanism has remained incompletely understood. Moreover, the evolutionary conservation of fasting regulation of SREBP-dependent programs of gene expression and control of lipid homeostasis has been unclear. We demonstrate here a conserved role for orthologs of the NAD(+)-dependent deacetylase SIRT1 in metazoans in down-regulation of SREBP orthologs during fasting, resulting in inhibition of lipid synthesis and fat storage. Our data reveal that SIRT1 can directly deacetylate SREBP, and modulation of SIRT1 activity results in changes in SREBP ubiquitination, protein stability, and target gene expression. In addition, chemical activators of SIRT1 inhibit SREBP target gene expression in vitro and in vivo, correlating with decreased hepatic lipid and cholesterol levels and attenuated liver steatosis in diet-induced and genetically obese mice. We conclude that SIRT1 orthologs play a critical role in controlling SREBP-dependent gene regulation governing lipid/cholesterol homeostasis in metazoans in response to fasting cues. These findings may have important biomedical implications for the treatment of metabolic disorders associated with aberrant lipid/cholesterol homeostasis, including metabolic syndrome and atherosclerosis.

Pubmed ID: 20595232 RIS Download

Mesh terms: Acetylation | Animals | Benzamides | Caenorhabditis elegans | Cell Line | Cholesterol | Down-Regulation | Fasting | HeLa Cells | Heterocyclic Compounds, 4 or More Rings | Humans | Lipids | Mice | Naphthols | Niacinamide | Protein Stability | Sirtuin 1 | Sirtuins | Sterol Regulatory Element Binding Protein 1 | Sterol Regulatory Element Binding Protein 2

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIGMS NIH HHS, Id: R01 GM071449
  • Agency: NIGMS NIH HHS, Id: R01 GM053203
  • Agency: NIGMS NIH HHS, Id: R01 GM093072
  • Agency: NIGMS NIH HHS, Id: R01GM53203
  • Agency: NIDDK NIH HHS, Id: R01DK07833
  • Agency: NIDDK NIH HHS, Id: R01 DK084352
  • Agency: NIGMS NIH HHS, Id: R01GM071449
  • Agency: NIDDK NIH HHS, Id: R01 DK088190

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.